ZNF419 and cancer: As a result, the significant relationship of ZNF419 with T stage (e.g., BLCA) or M stage (e.g., KIRP) may illuminate the dominant malignant phenotype of ZNF419 in either tumor development or metastasis in different cancer types, possibly resulting from tissue heterogeneity-induced epigenetic regulation.